Published in Women's Health Weekly, April 1st, 2000
The study compared the commercial brands Mircette and Alesse, containing 20 mcg of ethinyl estradiol (EE), to Ortho Tri-Cyclen (35 mcg EE).
The study is the first large, controlled clinical trial to directly compare 20 mcg and 35 mcg pills. Researchers found that common side effects such as bloating, breast tenderness, and nausea were approximately 50% more common in women using Ortho Tri-Cyclen as compared to Mircette and Alesse.
Side effects, particularly in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.